148 related articles for article (PubMed ID: 18257694)
1. Failure of decolonization in patients with infections due to mupirocin-resistant strains of community-associated methicillin-resistant Staphylococcus aureus.
Graber CJ; Schwartz BS
Infect Control Hosp Epidemiol; 2008 Mar; 29(3):284; author reply 284-5. PubMed ID: 18257694
[No Abstract] [Full Text] [Related]
2. Does nasal colonization or mupirocin treatment affect recurrence of methicillin-resistant Staphylococcus aureus skin and skin structure infections?
Rahimian J; Khan R; LaScalea KA
Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1415-6. PubMed ID: 17952848
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.
Biedenbach DJ; Bouchillon SK; Johnson SA; Hoban DJ; Hackel M
Clin Ther; 2014 Jun; 36(6):953-60. PubMed ID: 24835558
[TBL] [Abstract][Full Text] [Related]
4. Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts.
Manian FA
Clin Infect Dis; 2003 Jan; 36(2):e26-8. PubMed ID: 12522764
[TBL] [Abstract][Full Text] [Related]
5. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.
McNeil JC; Hulten KG; Kaplan SL; Mason EO
Antimicrob Agents Chemother; 2011 May; 55(5):2431-3. PubMed ID: 21282426
[TBL] [Abstract][Full Text] [Related]
6. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.
Fritz SA; Hogan PG; Camins BC; Ainsworth AJ; Patrick C; Martin MS; Krauss MJ; Rodriguez M; Burnham CA
Antimicrob Agents Chemother; 2013 Jan; 57(1):559-68. PubMed ID: 23147738
[TBL] [Abstract][Full Text] [Related]
7. Surveillance for mupirocin resistance among methicillin-resistant Staphylococcus aureus clinical isolates.
Mongkolrattanothai K; Mankin P; Raju V; Gray B
Infect Control Hosp Epidemiol; 2008 Oct; 29(10):993-4. PubMed ID: 18808349
[No Abstract] [Full Text] [Related]
8. Elimination of a community-acquired methicillin-resistant Staphylococcus aureus infection in a nurse with atopic dermatitis.
Roesch A; Linde HJ; Landthaler M; Vogt T
Arch Dermatol; 2005 Dec; 141(12):1520-2. PubMed ID: 16365252
[No Abstract] [Full Text] [Related]
9. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?
Walker ES; Vasquez JE; Dula R; Bullock H; Sarubbi FA
Infect Control Hosp Epidemiol; 2003 May; 24(5):342-6. PubMed ID: 12785407
[TBL] [Abstract][Full Text] [Related]
10. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center.
Han LL; McDougal LK; Gorwitz RJ; Mayer KH; Patel JB; Sennott JM; Fontana JL
J Clin Microbiol; 2007 Apr; 45(4):1350-2. PubMed ID: 17287335
[TBL] [Abstract][Full Text] [Related]
11. High-level mupirocin resistance among Spanish methicillin-resistant Staphylococcus aureus.
Alarcón T; Sanz JC; Blanco F; Domingo D; López-Brea M
Eur J Clin Microbiol Infect Dis; 1998 Dec; 17(12):877-9. PubMed ID: 10052555
[TBL] [Abstract][Full Text] [Related]
12. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
Dolapçi I; Karahan ZC; Tekeli A; Koyuncu E; Azap A; Adaleti R
Mikrobiyol Bul; 2007 Jul; 41(3):435-40. PubMed ID: 17933255
[TBL] [Abstract][Full Text] [Related]
13. Mupirocin resistance in Staphylococcus aureus in an Indian hospital.
Gadepalli R; Dhawan B; Mohanty S; Kapil A; Das BK; Chaudhry R; Samantaray JC
Diagn Microbiol Infect Dis; 2007 May; 58(1):125-7. PubMed ID: 17240103
[TBL] [Abstract][Full Text] [Related]
14. High-level mupirocin resistance within methicillin-resistant Staphylococcus aureus pandemic lineages.
Pérez-Roth E; López-Aguilar C; Alcoba-Florez J; Méndez-Alvarez S
Antimicrob Agents Chemother; 2006 Sep; 50(9):3207-11. PubMed ID: 16940133
[TBL] [Abstract][Full Text] [Related]
15. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas.
Chavez-Bueno S; Bozdogan B; Katz K; Bowlware KL; Cushion N; Cavuoti D; Ahmad N; McCracken GH; Appelbaum PC
Antimicrob Agents Chemother; 2005 Jun; 49(6):2283-8. PubMed ID: 15917522
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus: an update for the dermatologist, Part 4: Additional therapeutic considerations.
Kil EH; Heymann WR; Weinberg JM
Cutis; 2008 Apr; 81(4):343-7. PubMed ID: 18491483
[TBL] [Abstract][Full Text] [Related]
17. The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus.
Gorwitz RJ
Clin Infect Dis; 2007 Mar; 44(6):785-7. PubMed ID: 17304448
[No Abstract] [Full Text] [Related]
18. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.
Jones JC; Rogers TJ; Brookmeyer P; Dunne WM; Storch GA; Coopersmith CM; Fraser VJ; Warren DK
Clin Infect Dis; 2007 Sep; 45(5):541-7. PubMed ID: 17682986
[TBL] [Abstract][Full Text] [Related]
19. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains.
Semret M; Miller MA
Infect Control Hosp Epidemiol; 2001 Sep; 22(9):578-80. PubMed ID: 11732789
[TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus: a community concern.
Hedge DD
S D Med; 2006 Oct; 59(10):433, 435. PubMed ID: 17124921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
